Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FYGC5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,139
Award facts
- Contract value 100% obligated
- $69,139.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $69,139.41 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectable medication. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 19, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle valued through December 2026 that enables the company to supply pharmaceuticals and medical supplies globally to support military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for the Defense Logistics Agency's Medical Supply Chain, providing a comprehensive range of brand-name and generic medications, vaccines, and specialized medical supplies to support military and veteran healthcare systems. The company's competitive contract awards with DLA demonstrate its capability to fulfill federal procurement requirements across multiple therapeutic domains, including this delivery order for Dupixent, a specialty immunosuppressant medication used in treating conditions such as eczema, asthma, and chronic rhinosinusitis.
Quick answers
Who was awarded contract SPE2DB25FYGC5?
SPE2DB25FYGC5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FYGC5 worth?
The government has obligated $69,139 on SPE2DB25FYGC5.
Is contract SPE2DB25FYGC5 an order under another contract?
Yes. SPE2DB25FYGC5 is a delivery order under SPE2DB24D1104, an indefinite delivery contract.
Was contract SPE2DB25FYGC5 competed?
The extent of competition for SPE2DB25FYGC5 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award